{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T10:58:28Z","timestamp":1793703508892,"version":"4.5.1"},"reference-count":81,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01DA02976 (WKK)"],"award-info":[{"award-number":["R01DA02976 (WKK)"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01DA032889-02 (JMD)"],"award-info":[{"award-number":["R01DA032889-02 (JMD)"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["seminperinat.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Perinatology"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1053\/j.semperi.2015.12.007","type":"journal-article","created":{"date-parts":[[2016,1,12]],"date-time":"2016-01-12T07:26:05Z","timestamp":1452583565000},"page":"203-212","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":61,"title":["Neonatal abstinence syndrome: Pharmacologic strategies for the mother and infant"],"prefix":"10.1053","volume":"40","author":[{"given":"Walter K.","family":"Kraft","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan W.","family":"Stover","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan M.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.semperi.2015.12.007_bib1","first-page":"563","article-title":"Vital signs: Variation among states in prescribing opioid pain relievers and benzodiazepines\u2014United States, 2012","volume":"63","author":"Paulozzi","year":"2014","journal-title":"Morb Mortal Wkly Rep"},{"key":"10.1053\/j.semperi.2015.12.007_bib2","first-page":"37","article-title":"Opioid prescription claims among women of reproductive age\u2014United States, 2008\u20132012","volume":"64","author":"Ailes","year":"2015","journal-title":"Morb Mortal Wkly Rep"},{"key":"10.1053\/j.semperi.2015.12.007_bib3","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1001\/jama.2012.3951","article-title":"Neonatal abstinence syndrome and associated health care expenditures: United States, 2000\u20132009","volume":"307","author":"Patrick","year":"2012","journal-title":"J Am Med Assoc"},{"key":"10.1053\/j.semperi.2015.12.007_bib4","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1056\/NEJMsa1500439","article-title":"Increasing incidence of the neonatal abstinence syndrome in U.S. neonatal ICUs","volume":"372","author":"Tolia","year":"2015","journal-title":"New Engl J Med"},{"key":"10.1053\/j.semperi.2015.12.007_bib5","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/ADM.0b013e3182266a3a","article-title":"The relationship between maternal opioid agonists and psychiatric medications on length of hospitalization for neonatal abstinence syndrome","volume":"5","author":"Wachman","year":"2011","journal-title":"J Addict Med"},{"key":"10.1053\/j.semperi.2015.12.007_bib6","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.drugalcdep.2012.11.019","article-title":"Cigarette smoking in opioid-dependent pregnant women: neonatal and maternal outcomes","volume":"131","author":"Jones","year":"2013","journal-title":"Drug Alcohol Depend"},{"key":"10.1053\/j.semperi.2015.12.007_bib7","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1542\/peds.2014-3299","article-title":"Prescription opioid epidemic and infant outcomes","volume":"135","author":"Patrick","year":"2015","journal-title":"Pediatrics"},{"key":"10.1053\/j.semperi.2015.12.007_bib8","doi-asserted-by":"crossref","first-page":"e391","DOI":"10.1016\/j.ajog.2008.06.088","article-title":"Predicting length of treatment for neonatal abstinence syndrome in methadone-exposed neonates","volume":"199","author":"Seligman","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"10.1053\/j.semperi.2015.12.007_bib9","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/j.1479-828X.2005.00379.x","article-title":"Substance use during pregnancy: risk factors and obstetric and perinatal outcomes in South Australia","volume":"45","author":"Kennare","year":"2005","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"10.1053\/j.semperi.2015.12.007_bib10","series-title":"SAHMSA\/CSAT Treatment Improvement Protocols","article-title":"Medication-assisted treatment for opioid addiction during pregnancy","author":"Center for Substance Abuse Treatment","year":"2008"},{"key":"10.1053\/j.semperi.2015.12.007_bib11","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0899-3289(20)30008-0","article-title":"Altered methadone pharmacokinetics in pregnancy: implications for dosing","volume":"1","author":"Swift","year":"1989","journal-title":"J Subst Abuse"},{"key":"10.1053\/j.semperi.2015.12.007_bib12","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/AOG.0000000000000640","article-title":"Buprenorphine and naloxone compared with methadone treatment in pregnancy","volume":"125","author":"Wiegand","year":"2015","journal-title":"Obstet Gynecol"},{"key":"10.1053\/j.semperi.2015.12.007_bib13","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/clpt.1994.71","article-title":"Clinical pharmacology of buprenorphine: ceiling effects at high doses","volume":"55","author":"Walsh","year":"1994","journal-title":"Clin Pharmacol Ther"},{"key":"10.1053\/j.semperi.2015.12.007_bib14","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.drugalcdep.2009.03.020","article-title":"Comparing overdose mortality associated with methadone and buprenorphine treatment","volume":"104","author":"Bell","year":"2009","journal-title":"Drug Alcohol Depend"},{"issue":"suppl 1","key":"10.1053\/j.semperi.2015.12.007_bib15","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1360-0443.2012.04035.x","article-title":"Buprenorphine treatment of opioid-dependent pregnant women: a comprehensive review","volume":"107","author":"Jones","year":"2012","journal-title":"Addiction"},{"key":"10.1053\/j.semperi.2015.12.007_bib16","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1056\/NEJMoa1005359","article-title":"Neonatal abstinence syndrome after methadone or buprenorphine exposure","volume":"363","author":"Jones","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1053\/j.semperi.2015.12.007_bib17","doi-asserted-by":"crossref","first-page":"S87","DOI":"10.1016\/S0376-8716(03)00062-0","article-title":"Use of buprenorphine in pregnancy: patient management and effects on the neonate","volume":"70","author":"Johnson","year":"2003","journal-title":"Drug Acohol Depend"},{"key":"10.1053\/j.semperi.2015.12.007_bib18","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1097\/AOG.0b013e318256496e","article-title":"ACOG Committee opinion no. 524: opioid abuse, dependence, and addiction in pregnncy","volume":"119","author":"Committee on Health Care for Underserved Women","year":"2012","journal-title":"Obstet Gynecol"},{"key":"10.1053\/j.semperi.2015.12.007_bib19","doi-asserted-by":"crossref","first-page":"47","DOI":"10.5055\/jom.2009.0006","article-title":"The opioid-exposed newborn: assessment and pharmacologic management","volume":"5","author":"Jansson","year":"2009","journal-title":"J Opioid Manag"},{"key":"10.1053\/j.semperi.2015.12.007_bib20","doi-asserted-by":"crossref","first-page":"e547","DOI":"10.1542\/peds.2013-3524","article-title":"Neonatal abstinence syndrome","volume":"134","author":"Kocherlakota","year":"2014","journal-title":"Pediatrics"},{"key":"10.1053\/j.semperi.2015.12.007_bib21","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0376-8716(96)01236-7","article-title":"Role of noradrenergic hyperactivity in neonatal opiate abstinence","volume":"41","author":"Little","year":"1996","journal-title":"Drug Alcohol Depend"},{"key":"10.1053\/j.semperi.2015.12.007_bib22","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1111\/j.1460-9568.2005.04416.x","article-title":"Morphine withdrawal-induced morphological changes in the nucleus accumbens","volume":"22","author":"Spiga","year":"2005","journal-title":"Eur J Neurosci"},{"key":"10.1053\/j.semperi.2015.12.007_bib23","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.neuroscience.2013.08.071","article-title":"Opiate exposure and withdrawal dynamically regulate mRNA expression in the serotonergic dorsal raphe nucleus","volume":"254","author":"Lunden","year":"2013","journal-title":"Neuroscience"},{"key":"10.1053\/j.semperi.2015.12.007_bib24","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1111\/j.1360-0443.2009.02802.x","article-title":"Finnegan neonatal abstinence scoring system: normal values for first 3 days and weeks 5\u20136 in non-addicted infants","volume":"105","author":"Zimmerman-Baer","year":"2010","journal-title":"Addiction"},{"key":"10.1053\/j.semperi.2015.12.007_bib25","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1097\/FTD.0b013e31828a6148","article-title":"Alternative matrices for cocaine, heroin, and methadone in utero drug exposure detection","volume":"35","author":"Concheiro","year":"2013","journal-title":"Ther Drug Monit"},{"key":"10.1053\/j.semperi.2015.12.007_bib26","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1203\/PDR.0b013e3181bc035d","article-title":"Prenatal methadone exposure and neonatal neurobehavioral functioning","volume":"66","author":"Velez","year":"2009","journal-title":"Pediatr Res"},{"key":"10.1053\/j.semperi.2015.12.007_bib27","doi-asserted-by":"crossref","first-page":"e540","DOI":"10.1542\/peds.2011-3212","article-title":"Neonatal drug withdrawal","volume":"129","author":"Hudak","year":"2012","journal-title":"Pediatrics"},{"key":"10.1053\/j.semperi.2015.12.007_bib28","doi-asserted-by":"crossref","first-page":"e1163","DOI":"10.1542\/peds.2005-1561","article-title":"Effects of breast milk on the severity and outcome of neonatal abstinence syndrome among infants of drug-dependent mothers","volume":"117","author":"Abdel-Latif","year":"2006","journal-title":"Pediatrics"},{"key":"10.1053\/j.semperi.2015.12.007_bib29","first-page":"213","article-title":"Infant and maternal characteristics in neonatal abstinence syndrome\u2014selected hospitals in Florida, 2010\u20132011","volume":"64","author":"Lind","year":"2015","journal-title":"Morb Mortal Wkly Rep"},{"key":"10.1053\/j.semperi.2015.12.007_bib30","doi-asserted-by":"crossref","first-page":"e527","DOI":"10.1542\/peds.2013-4036","article-title":"A multicenter cohort study of treatments and hospital outcomes in neonatal abstinence syndrome","volume":"134","author":"Hall","year":"2014","journal-title":"Pediatrics"},{"key":"10.1053\/j.semperi.2015.12.007_bib31","first-page":"CD002059","article-title":"Opiate treatment for opiate withdrawal in newborn infants","volume":"10","author":"Osborn","year":"2010","journal-title":"Cochrane Data Syst Rev"},{"key":"10.1053\/j.semperi.2015.12.007_bib32","first-page":"CD002053","article-title":"Sedatives for opiate withdrawal in newborn infants","volume":"10","author":"Osborn","year":"2010","journal-title":"Cochrane Data Syst Rev"},{"key":"10.1053\/j.semperi.2015.12.007_bib33","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1097\/MOP.0b013e32834fdc3a","article-title":"Neonatal abstinence syndrome","volume":"24","author":"Jansson","year":"2012","journal-title":"Curr Opin Pediatr"},{"key":"10.1053\/j.semperi.2015.12.007_bib34","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1038\/jp.2014.114","article-title":"Variation in treatment of neonatal abstinence syndrome in US children\u2019s hospitals, 2004\u20132011","volume":"34","author":"Patrick","year":"2014","journal-title":"J Perinatol"},{"key":"10.1053\/j.semperi.2015.12.007_bib35","doi-asserted-by":"crossref","first-page":"F249","DOI":"10.1136\/adc.2008.152769","article-title":"Management of neonatal abstinence syndrome: a national survey and review of practice","volume":"94","author":"O\u2019Grady","year":"2009","journal-title":"Arch Dis Child Fetal Neonat"},{"key":"10.1053\/j.semperi.2015.12.007_bib36","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/sj.jp.7211427","article-title":"Management of neonatal abstinence syndrome in neonatal intensive care units: a national survey","volume":"26","author":"Sarkar","year":"2006","journal-title":"J Perinatol"},{"key":"10.1053\/j.semperi.2015.12.007_bib37","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1093\/bja\/aeh042","article-title":"Developmental pharmacokinetics of morphine and its metabolites in neonates, infants and young children","volume":"92","author":"Boumeester","year":"2004","journal-title":"Br J Anaesth"},{"key":"10.1053\/j.semperi.2015.12.007_bib38","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.phrs.2004.05.002","article-title":"Methadone\u2014metabolism, pharmacokinetics and interactions","volume":"50","author":"Ferrari","year":"2004","journal-title":"Pharmacol Res"},{"key":"10.1053\/j.semperi.2015.12.007_bib39","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s10928-006-9018-0","article-title":"Population-based analysis of methadone distribution and metabolism using an age-dependent physiologically based pharmacokinetic model","volume":"33","author":"Yang","year":"2006","journal-title":"J Pharmacokinet Pharmacodyn"},{"key":"10.1053\/j.semperi.2015.12.007_bib40","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1111\/pan.12385","article-title":"The pharmacokinetics of methadone and its metabolites in neonates, infants, and children","volume":"24","author":"Ward","year":"2014","journal-title":"Paediatr Anaesth"},{"issue":"6","key":"10.1053\/j.semperi.2015.12.007_bib41","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.jpeds.2015.08.032","article-title":"Pharmacokinetics of oral methadone in the treatment of neonatal abstinence syndrome: a pilot study","volume":"167","author":"Wiles","year":"2015","journal-title":"J Pediatr"},{"key":"10.1053\/j.semperi.2015.12.007_bib42","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.adnc.2005.06.003","article-title":"A retrospective study of length of hospital stay in infants treated for neonatal abstinence syndrome with methadone versus oral morphine preparations","volume":"5","author":"Lainwala","year":"2005","journal-title":"Adv Neonatal Care"},{"key":"10.1053\/j.semperi.2015.12.007_bib43","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/jp.2014.194","article-title":"Methadone versus morphine for treatment of neonatal abstinence syndrome: a prospective randomized clinical trial","volume":"35","author":"Brown","year":"2015","journal-title":"J Perinatol"},{"key":"10.1053\/j.semperi.2015.12.007_bib44","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1111\/j.1360-0443.2010.03170.x","article-title":"Revised dose schema of sublingual buprenorphine in the treatment of the neonatal opioid abstinence syndrome","volume":"106","author":"Kraft","year":"2011","journal-title":"Addiction"},{"key":"10.1053\/j.semperi.2015.12.007_bib45","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.curtheres.2014.09.002","article-title":"Ethanol pharmacokinetics in neonates and infants","volume":"76","author":"Marek","year":"2014","journal-title":"Cur Ther Res Clin Exp"},{"key":"10.1053\/j.semperi.2015.12.007_bib46","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1002\/phar.1610","article-title":"Population pharmacokinetic model of sublingual buprenorphine in neonatal abstinence syndrome","volume":"35","author":"Ng","year":"2015","journal-title":"Pharmacotherapy"},{"key":"10.1053\/j.semperi.2015.12.007_bib47","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1067\/mpd.2002.123099","article-title":"Diluted tincture of opium and phenobarbital versus DTO alone for neonatal opiate withdrawal in term infants","volume":"140","author":"Coyle","year":"2002","journal-title":"J Pediatr"},{"key":"10.1053\/j.semperi.2015.12.007_bib48","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1038\/jp.2013.95","article-title":"Efficacy of clonidine versus phenobarbital in reducing neonatal morphine sulfate therapy days for neonatal abstinence syndrome. A prospective randomized clinical trial","volume":"33","author":"Surran","year":"2013","journal-title":"J Perinatol"},{"key":"10.1053\/j.semperi.2015.12.007_bib49","doi-asserted-by":"crossref","first-page":"F300","DOI":"10.1136\/adc.2003.033555","article-title":"A randomised controlled trial of morphine versus phenobarbitone for neonatal abstinence syndrome","volume":"89","author":"Jackson","year":"2004","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"10.1053\/j.semperi.2015.12.007_bib50","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1002\/cpt1978233346","article-title":"Phenobarbital pharmacokinetics in neonates","volume":"23","author":"Pitlick","year":"1978","journal-title":"Clin Pharm Ther"},{"key":"10.1053\/j.semperi.2015.12.007_bib51","first-page":"329","article-title":"The use of phenobarbital in treating abstinence in newborns exposed in utero to psychoactive agents","volume":"49","author":"Finnegan","year":"1984","journal-title":"NIDA Res Monogr"},{"key":"10.1053\/j.semperi.2015.12.007_bib52","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1177\/0883073808321056","article-title":"Neonatal seizures: treatment and treatment variability in 31 United States pediatric hospitals","volume":"24","author":"Blume","year":"2009","journal-title":"J Child Neurol"},{"key":"10.1053\/j.semperi.2015.12.007_bib53","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/ana.23600","article-title":"Neonatal exposure to antiepileptic drugs disrupts striatal synaptic development","volume":"72","author":"Forcelli","year":"2012","journal-title":"Ann Neurol"},{"key":"10.1053\/j.semperi.2015.12.007_bib54","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1067\/mob.2002.122445","article-title":"Neurodevelopmental outcome of premature infants after antenatal phenobarbital exposure","volume":"187","author":"Shankaran","year":"2002","journal-title":"Am J Obstet Gynecol"},{"key":"10.1053\/j.semperi.2015.12.007_bib55","first-page":"CD002024","article-title":"Alpha2-adrenergic agonists for the management of opioid withdrawal","volume":"3","author":"Gowing","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1053\/j.semperi.2015.12.007_bib56","doi-asserted-by":"crossref","first-page":"e849","DOI":"10.1542\/peds.2008-0978","article-title":"Clonidine as an adjunct therapy to opioids for neonatal abstinence syndrome: a randomized, controlled trial","volume":"123","author":"Agthe","year":"2009","journal-title":"Pediatrics"},{"key":"10.1053\/j.semperi.2015.12.007_bib57","doi-asserted-by":"crossref","first-page":"e383","DOI":"10.1542\/peds.2014-2377","article-title":"Morphine versus clonidine for neonatal abstinence syndrome","volume":"135","author":"Bada","year":"2015","journal-title":"Pediatrics"},{"key":"10.1053\/j.semperi.2015.12.007_bib58","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s40272-014-0096-y","article-title":"Oral morphine weaning for neonatal abstinence syndrome at home compared with in-hospital: an observational cohort study","volume":"17","author":"Kelly","year":"2015","journal-title":"Paediatr Drugs"},{"key":"10.1053\/j.semperi.2015.12.007_bib59","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.chiabu.2009.09.012","article-title":"Neurodevelopmental and psychological assessment of adolescents born to drug-addicted parents: effects of SES and adoption","volume":"34","author":"Ornoy","year":"2010","journal-title":"Child Abuse Negl"},{"key":"10.1053\/j.semperi.2015.12.007_bib60","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0378-4274(02)00505-2","article-title":"The impact of intrauterine exposure versus postnatal environment in neurodevelopmental toxicity: long-term neurobehavioral studies in children at risk for developmental disorders","volume":"140","author":"Ornoy","year":"2003","journal-title":"Toxicol Lett"},{"key":"10.1053\/j.semperi.2015.12.007_bib61","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/j.neuroimage.2007.03.070","article-title":"Volumetric cerebral characteristics of children exposed to opiates and other substances in utero","volume":"36","author":"Walhovd","year":"2007","journal-title":"Neuroimage"},{"key":"10.1053\/j.semperi.2015.12.007_bib62","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.jpeds.2010.03.033","article-title":"Relationship between maternal methadone dose at delivery and neonatal abstinence syndrome","volume":"157","author":"Seligman","year":"2010","journal-title":"J Pediatr"},{"issue":"suppl 1","key":"10.1053\/j.semperi.2015.12.007_bib63","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1360-0443.2012.04038.x","article-title":"Predicting treatment for neonatal abstinence syndrome in infants born to women maintained on opioid agonist medication","volume":"107","author":"Kaltenbach","year":"2012","journal-title":"Addiction"},{"key":"10.1053\/j.semperi.2015.12.007_bib64","first-page":"1244","article-title":"Relationship between maternal methadone dosage and neonatal withdrawal","volume":"100","author":"Dashe","year":"2002","journal-title":"Obstet Gynecol"},{"key":"10.1053\/j.semperi.2015.12.007_bib65","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.drugalcdep.2013.11.006","article-title":"Neonatal outcomes and their relationship to maternal buprenorphine dose during pregnancy","volume":"134","author":"Jones","year":"2014","journal-title":"Drug Alcohol Depend"},{"key":"10.1053\/j.semperi.2015.12.007_bib66","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1111\/j.1651-2227.2008.00838.x","article-title":"Neonatal outcome of 58 infants exposed to maternal buprenorphine in utero","volume":"97","author":"Hytinantti","year":"2008","journal-title":"Acta Paediatr"},{"key":"10.1053\/j.semperi.2015.12.007_bib67","first-page":"CD006318","article-title":"Maintenance agonist treatments for opiate-dependent pregnant women","volume":"12","author":"Minozzi","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1053\/j.semperi.2015.12.007_bib68","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/j.1521-0391.2012.12005.x","article-title":"Buprenorphine + naloxone in the treatment of opioid dependence during pregnancy-initial patient care and outcome data","volume":"22","author":"Debelak","year":"2013","journal-title":"Am J Addict"},{"key":"10.1053\/j.semperi.2015.12.007_bib69","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1177\/000992289002900208","article-title":"Diazepam abuse in pregnant women on methadone maintenance. Implications for the neonate","volume":"29","author":"Sutton","year":"1990","journal-title":"Clin Pediatr"},{"key":"10.1053\/j.semperi.2015.12.007_bib70","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/S0022-3476(05)82214-0","article-title":"Neonatal opiate abstinence syndrome in term and preterm infants","volume":"118","author":"Doberczak","year":"1991","journal-title":"J Pediatr"},{"key":"10.1053\/j.semperi.2015.12.007_bib71","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1001\/archpsyc.57.3.261","article-title":"Illicit psychoactive substance use, heavy use, abuse, and dependence in a US population-based sample of male twins","volume":"57","author":"Kendler","year":"2000","journal-title":"Arch Gen Psychiatry"},{"key":"10.1053\/j.semperi.2015.12.007_bib72","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.drugalcdep.2009.12.016","article-title":"OPRM1 SNP (A118G): involvement in disease development, treatment response, and animal models","volume":"108","author":"Mague","year":"2010","journal-title":"Drug Alcohol Depend"},{"key":"10.1053\/j.semperi.2015.12.007_bib73","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/nrg1635","article-title":"The genetics of addictions: uncovering the genes","volume":"6","author":"Goldman","year":"2005","journal-title":"Nat Rev Genet"},{"key":"10.1053\/j.semperi.2015.12.007_bib74","doi-asserted-by":"crossref","first-page":"983","DOI":"10.2165\/00003088-200443140-00003","article-title":"Genetic predictors of the clinical response to opioid analgesics: clinical utility and future perspectives","volume":"43","author":"Lotsch","year":"2004","journal-title":"Clin Pharmacokinet"},{"key":"10.1053\/j.semperi.2015.12.007_bib75","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1001\/jama.2013.3411","article-title":"Association of OPRM1 and COMT single-nucleotide polymorphisms with hospital length of stay and treatment of neonatal abstinence syndrome","volume":"309","author":"Wachman","year":"2013","journal-title":"J Am Med Assoc"},{"key":"10.1053\/j.semperi.2015.12.007_bib76","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2015.07.001","article-title":"Variations in opioid receptor genes in neonatal abstinence syndrome","author":"Wachman","year":"2015","journal-title":"Drug Alcohol Depend"},{"key":"10.1053\/j.semperi.2015.12.007_bib77","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.jpeds.2014.05.040","article-title":"Epigenetic variation in the mu-opioid receptor gene in infants with neonatal abstinence syndrome","volume":"165","author":"Wachman","year":"2014","journal-title":"J Pediatr"},{"key":"10.1053\/j.semperi.2015.12.007_bib78","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.cct.2014.08.009","article-title":"Design considerations for point-of-care clinical trials comparing methadone and buprenorphine treatment for opioid dependence in pregnancy and for neonatal abstinence syndrome","volume":"39","author":"Winhusen","year":"2014","journal-title":"Contemp Clin Trials"},{"key":"10.1053\/j.semperi.2015.12.007_bib79","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/cpt.5","article-title":"Ondansetron pharmacokinetics in pregnant women and neonates: towards a new treatment for neonatal abstinence syndrome","volume":"97","author":"Elkomy","year":"2015","journal-title":"Clin Pharm Ther"},{"key":"10.1053\/j.semperi.2015.12.007_bib80","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1177\/0091270010370587","article-title":"Clonidine clearance matures rapidly during the early postnatal period: a population pharmacokinetic analysis in newborns with neonatal abstinence syndrome","volume":"51","author":"Xie","year":"2011","journal-title":"J Clin Pharmacol"},{"key":"10.1053\/j.semperi.2015.12.007_bib81","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1002\/cpt.166","article-title":"Neonatal drug therapy: the first frontier of therapeutics for children","volume":"98","author":"Allegaert","year":"2015","journal-title":"Clin Pharm Ther"}],"container-title":["Seminars in Perinatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0146000515001974?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0146000515001974?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T12:06:09Z","timestamp":1654085169000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0146000515001974"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":81,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["S0146000515001974"],"URL":"https:\/\/doi.org\/10.1053\/j.semperi.2015.12.007","relation":{},"ISSN":["0146-0005"],"issn-type":[{"value":"0146-0005","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neonatal abstinence syndrome: Pharmacologic strategies for the mother and infant","name":"articletitle","label":"Article Title"},{"value":"Seminars in Perinatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.semperi.2015.12.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}